Abstract

The characteristics of α 1-adrenergic receptors were investigated in perfused rat hearts at 37°C. [ 3H]Prazosin was bound in a time-dependent manner and reached equilibrium at 15 min. Scatchard analysis of the specific binding isotherm for [ 3H]prazosin indicated a population of high affinity sites ( K d = 0.41 n m, B max = 13.2 pmol/g wet wt). Prazosin binding was displaced by epinephrine as well as by the adrenergic antagonists prazosin > phentolamine > yohimbine > propranolol. Specific prazosin binding was defined as that portion of the binding inhibited by 10 μ m phentolamine; phentolamine and epinephrine displaced 3H-prazosin to the same level. [ 3H]Prazosin was not metabolized by the heart. When pre-labelled hearts were perfused at 37°C with prazosin-free medium non-specific binding of [ 3H]prazosin decreased more rapidly ( t 0.5 = 4 min) than specific binding ( t 0.5 = 38 min). Perfusion of the heart at lower temperatures (< 10°C) decreased the rate of loss of nonspecific binding and prevented the loss of specific binding. Fractionation of [ 3H]prazosin perfused hearts at 0°C, when dissociation was minimal, led to a loss of binding so that sarcolemma-enriched fractions contained approximately 2% of the binding sites present in the perfused heart. The binding characteristics of sarcolemma-enriched fractions ( K d 0.10 n m, B max 300 fmol/mg protein) differed significantly from those of the perfused heart. Exposure of the heart to 10 min of ischaemia prior to binding studies did not alter the characteristics of the [ 3H]prazosin binding sites. It is concluded that the perfused rat heart contains a population of α 1-adrenoceptors which differ from those of isolated sarcolemma preparations perhaps because of alterations that occur during sarcolemma isolation. The perfused heart should be an appropriate model system in which to study the relationship between receptor occupancy and biological response as well as the direct effects of perturbations such as ischaemia.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.